JP2024509792A5 - - Google Patents
Info
- Publication number
- JP2024509792A5 JP2024509792A5 JP2023552146A JP2023552146A JP2024509792A5 JP 2024509792 A5 JP2024509792 A5 JP 2024509792A5 JP 2023552146 A JP2023552146 A JP 2023552146A JP 2023552146 A JP2023552146 A JP 2023552146A JP 2024509792 A5 JP2024509792 A5 JP 2024509792A5
- Authority
- JP
- Japan
- Prior art keywords
- capsid
- raav
- vector
- itr
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163154485P | 2021-02-26 | 2021-02-26 | |
| US63/154,485 | 2021-02-26 | ||
| PCT/US2022/017998 WO2022183052A1 (en) | 2021-02-26 | 2022-02-25 | Composition and methods for the treatment of fabry disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509792A JP2024509792A (ja) | 2024-03-05 |
| JP2024509792A5 true JP2024509792A5 (https=) | 2025-03-03 |
Family
ID=80786597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023552146A Withdrawn JP2024509792A (ja) | 2021-02-26 | 2022-02-25 | ファブリー病の治療のための組成物及び方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240175054A1 (https=) |
| EP (1) | EP4298227A1 (https=) |
| JP (1) | JP2024509792A (https=) |
| KR (1) | KR20230150836A (https=) |
| CN (1) | CN117321212A (https=) |
| AR (1) | AR124981A1 (https=) |
| AU (1) | AU2022227017A1 (https=) |
| BR (1) | BR112023016983A2 (https=) |
| CA (1) | CA3209673A1 (https=) |
| CL (1) | CL2023002530A1 (https=) |
| CO (1) | CO2023011012A2 (https=) |
| EC (1) | ECSP23072174A (https=) |
| IL (1) | IL305440A (https=) |
| MX (1) | MX2023009978A (https=) |
| PE (1) | PE20240806A1 (https=) |
| TW (1) | TW202302855A (https=) |
| WO (1) | WO2022183052A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023331251A1 (en) * | 2022-08-25 | 2025-02-27 | Takeda Pharmaceutical Company Limited | Composition for use in the treatment of fabry disease |
| AU2024257162A1 (en) * | 2023-04-17 | 2025-11-06 | Exegenesis Bio Singapore Pte. Ltd. | Compositions and methods for gene therapies |
| WO2024236544A1 (en) | 2023-05-17 | 2024-11-21 | Takeda Pharmaceutical Company Limited | Pet tracer compounds for tracing alpha-galactosidase a and reaction intermediates, and methods of use |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5436146A (en) | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
| US6268213B1 (en) | 1992-06-03 | 2001-07-31 | Richard Jude Samulski | Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US5869305A (en) | 1992-12-04 | 1999-02-09 | The University Of Pittsburgh | Recombinant viral vector system |
| US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US5741683A (en) | 1995-06-07 | 1998-04-21 | The Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| US6548286B1 (en) | 1997-04-14 | 2003-04-15 | Cell Genesys, Inc. | Methods for increasing the efficiency of recombinant AAV product |
| US6146874A (en) | 1998-05-27 | 2000-11-14 | University Of Florida | Method of preparing recombinant adeno-associated virus compositions |
| AU780231B2 (en) | 1998-11-10 | 2005-03-10 | University Of North Carolina At Chapel Hill, The | Virus vectors and methods of making and administering the same |
| US7201898B2 (en) | 2000-06-01 | 2007-04-10 | The University Of North Carolina At Chapel Hill | Methods and compounds for controlled release of recombinant parvovirus vectors |
| MX359371B (es) | 2001-11-13 | 2018-09-25 | Univ Pennsylvania | Un metodo para detectar y/o identificar secuencias del virus adeno-asociado y aislamiento de secuencias novedosas identificadas de ese modo. |
| PT1453547T (pt) | 2001-12-17 | 2016-12-28 | Univ Pennsylvania | Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas |
| AU2003274397A1 (en) | 2002-06-05 | 2003-12-22 | University Of Florida | Production of pseudotyped recombinant aav virions |
| EP2345731B1 (en) | 2003-09-30 | 2015-10-21 | The Trustees of the University of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof |
| ES2525067T3 (es) | 2005-04-07 | 2014-12-17 | The Trustees Of The University Of Pennsylvania | Método de incremento de la función de un vector de AAV |
| US7588772B2 (en) | 2006-03-30 | 2009-09-15 | Board Of Trustees Of The Leland Stamford Junior University | AAV capsid library and AAV capsid proteins |
| US20120322861A1 (en) | 2007-02-23 | 2012-12-20 | Barry John Byrne | Compositions and Methods for Treating Diseases |
| US9249425B2 (en) | 2011-05-16 | 2016-02-02 | The Trustees Of The University Of Pennslyvania | Proviral plasmids and production of recombinant adeno-associated virus |
| WO2019222314A1 (en) * | 2018-05-15 | 2019-11-21 | University Of Massachusetts | Raav vectors encoding of lysosomal beta-galactorsidase (glb1) and cathepsin a |
| CN113631182B (zh) * | 2018-10-10 | 2025-03-21 | 阿米库斯治疗学公司 | 二硫键稳定的多肽组合物和使用方法 |
| KR20220022107A (ko) * | 2018-12-05 | 2022-02-24 | 아베오나 테라퓨틱스 인코퍼레이티드 | 유전자 전달을 위한 재조합 아데노-연관 바이러스 벡터 |
| AU2019403323B2 (en) * | 2018-12-20 | 2026-02-26 | Codexis, Inc. | Human alpha-galactosidase variants |
| CN113423419A (zh) * | 2019-01-04 | 2021-09-21 | 桑格摩生物治疗股份有限公司 | 用于治疗法布里病的方法和组合物 |
| AU2021356684A1 (en) * | 2020-10-09 | 2023-05-11 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of fabry disease |
-
2022
- 2022-02-25 AR ARP220100423A patent/AR124981A1/es unknown
- 2022-02-25 MX MX2023009978A patent/MX2023009978A/es unknown
- 2022-02-25 TW TW111107143A patent/TW202302855A/zh unknown
- 2022-02-25 WO PCT/US2022/017998 patent/WO2022183052A1/en not_active Ceased
- 2022-02-25 KR KR1020237032457A patent/KR20230150836A/ko active Pending
- 2022-02-25 PE PE2023002431A patent/PE20240806A1/es unknown
- 2022-02-25 CN CN202280030576.5A patent/CN117321212A/zh active Pending
- 2022-02-25 US US18/547,809 patent/US20240175054A1/en active Pending
- 2022-02-25 JP JP2023552146A patent/JP2024509792A/ja not_active Withdrawn
- 2022-02-25 BR BR112023016983A patent/BR112023016983A2/pt not_active Application Discontinuation
- 2022-02-25 IL IL305440A patent/IL305440A/en unknown
- 2022-02-25 EP EP22711380.0A patent/EP4298227A1/en active Pending
- 2022-02-25 AU AU2022227017A patent/AU2022227017A1/en not_active Abandoned
- 2022-02-25 CA CA3209673A patent/CA3209673A1/en active Pending
-
2023
- 2023-08-24 CO CONC2023/0011012A patent/CO2023011012A2/es unknown
- 2023-08-25 CL CL2023002530A patent/CL2023002530A1/es unknown
- 2023-09-22 EC ECSENADI202372174A patent/ECSP23072174A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509792A5 (https=) | ||
| US20210275614A1 (en) | Aav triple-plasmid system | |
| JP2019116492A5 (https=) | ||
| JP2021106619A5 (https=) | ||
| JP2022508182A5 (https=) | ||
| JP2021087431A5 (https=) | ||
| JP2021003120A5 (https=) | ||
| US8129510B2 (en) | Minigene expression cassette | |
| US20190032078A1 (en) | Gene therapy for juvenile batten disease | |
| JP2024099770A5 (https=) | ||
| JP2020537542A5 (https=) | ||
| US20260062682A1 (en) | Aav-mediated gene therapy for maple syrup urine disease (msud) | |
| JP2020054367A (ja) | 改変ｇ６ｐｃをコードするアデノ随伴ウイルスベクターおよびその使用 | |
| JP2022525302A5 (https=) | ||
| JP2022551744A5 (https=) | ||
| JP2022541070A5 (https=) | ||
| JP2024508696A5 (https=) | ||
| JP2021520811A5 (https=) | ||
| JP2025540074A (ja) | 繰り返しエレメントの適切なパッケージングのためのアデノ随伴ウイルスベクター | |
| Bulaklak et al. | Therapeutic advances in musculoskeletal AAV targeting approaches | |
| JP2023542241A5 (https=) | ||
| JP2022527126A5 (https=) | ||
| JP2025515030A5 (https=) | ||
| US12480098B1 (en) | Adeno-associated virus variant | |
| Kuranda et al. | AAV vector-based gene therapy, progress and current challenges |